Order Article Reprints

Beneduce G, De Matteo A, Stellato P, Testi AM, Bertorello N, Colombini A, Putti MC, Rizzari C, Cesaro S, Cellini M, et al. Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers. Cancers. 2022; 14(2):426. https://doi.org/10.3390/cancers14020426

Beneduce, Giuliana, Antonia De Matteo, Pio Stellato, Anna M. Testi, Nicoletta Bertorello, Antonella Colombini, Maria C. Putti, Carmelo Rizzari, Simone Cesaro, Monica Cellini, and et al. 2022. "Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers" Cancers 14, no. 2: 426. https://doi.org/10.3390/cancers14020426

Beneduce, G., De Matteo, A., Stellato, P., Testi, A. M., Bertorello, N., Colombini, A., Putti, M. C., Rizzari, C., Cesaro, S., Cellini, M., Barisone, E., Petruzziello, F., Menna, G., & Parasole, R. (2022). Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers. Cancers, 14(2), 426. https://doi.org/10.3390/cancers14020426